• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Serum level of microRNA in the chronic Hepatitis B have the relationship with liver failure

Serum level of microRNA in the chronic Hepatitis B have the relationship with liver failure

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户：wuhaoxin1987
【摘 要】
：
Background:To demonstrate whether miRNA in serum can serve as molecular markers to failure(LF) whether predict the long-term prognosis of patients.
【作 者】
：
Ya Wen 
【机 构】
：
Department of Infectious Disease,Xiangya Hospital,Central South University,Changsha,China
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
【发表日期】
：
2014年4期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:To demonstrate whether miRNA in serum can serve as molecular markers to failure(LF) whether predict the long-term prognosis of patients.
其他文献
Efficacy of various salvage therapy for chronic hepatitis B patients who failed both initial nucleos
Background:Entecavair(ETV) 1mg monotherapy was sometimes used for the chronic hepatitis B(CHB)patients with other nucleoside resistance in the past,but now,not recommended due to sequential resistance
会议
Non-invasive assessment of liver fibrosis:Can one size fit all?
In patients with chronic liver diseases,identification of significant liver fibrosis and cirrhosis is essential for determining treatment strategies,assessing therapeutic response,and stratifying long
会议
Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B vi
Background:Disruption of peripheral blood B-cell homeostasis and variation of surface receptors occur with certain infections and autoimmune diseases.However,the impact of antiviral therapy on B-cell
会议
Naturally occurring deletion/insertion mutations in hepatitis B virus core promoter confer different
Background:The core promoter(CP) of hepatitis B virus(HBV) plays a central role in viral replication and morphogenesis.The aim of this study was to characterize CP deletion(Del)/insertion(Ins) mutatio
会议
Transforming growth factor β-activated kinase 1 inhibits HBV replication and gene expression through
Background:Transforming growth factor β-activated kinase 1(TAK1) is a key mediator of innate immunity and proinflammatory signaling pathway.Previously,we found that TAK1 was involved in anti-HBV effec
会议
Incidence and determinants of HBsAg seroclearance and HBeAg seroconversion:a community-based follow-
Background:Seroclearance of HBsAg and HBeAg seroconversion are the important events in the natural history of the HBV infection.However,the spontaneous rates of HBsAg seroclearance,HBsAg seroconverion
会议
Elevated expression of chemokine CXCL13 in chronic hepatitis B patients links to immune control duri
Background:C-X-C-chemokine ligand 13(CXCL13),the ligand for C-X-C chemokine receptor type 5(CXCR5),is a major regulator of B-cell trafficking and plays an integral role in age-dependent clearance of H
会议
Predictors of the complete virologic response in na(i)ve chronic hepatitis B patients with entecavir
Background:We assessed baseline and on-treatment variables to determine predictive factors of the complete virologic response in na(i)ve chronic hepatitis B patients with entecavir therapy.
会议
Added value of new biomarkers over the aspartate aminotransferase-to-platelet ratio index for the pr
Background:The aspartate aminotransferase-to-platelet ratio index(APRI) has the advantage of including only two inexpensive routine laboratory tests and widespread availability,but it does not directl
会议
A PROSPECTIVE RANDOMIZED COMPARISON OF 5YEARS TREATMENT EFFICACY BETWEEN ENTECAVIR AND ADEFOVIR IN T
Background:Entecavir(ETV) and adefovir(ADV) had been considered as first line treatment of Chronic hepatitis B(CHB).But there are little prospective data comparing long term efficacy and safety of bot
会议